Next Article in Journal
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study
Next Article in Special Issue
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
Previous Article in Journal
Increased Sensitivity of Computed Tomography Scan for Neoplastic Tissues Using the Extracellular Vesicle Formulation of the Contrast Agent Iohexol
Previous Article in Special Issue
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(12), 2767; https://doi.org/10.3390/pharmaceutics14122767
Action Date Notes Link
article xml file uploaded 10 December 2022 10:33 CET Original file -
article xml uploaded. 10 December 2022 10:33 CET Update https://www.mdpi.com/1999-4923/14/12/2767/xml
article pdf uploaded. 10 December 2022 10:33 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2767/pdf
article html file updated 10 December 2022 10:35 CET Original file -
article html file updated 1 March 2023 03:36 CET Update -
article html file updated 4 March 2023 20:43 CET Update https://www.mdpi.com/1999-4923/14/12/2767/html
Back to TopTop